Rivogenlecleucel

DB19107InvestigationalCell transplant therapies

Rivogenlecleucel: Overview.

Mechanism
Curator reviewed
Also known as
Allogeneic T-Lymphocytes BPX-501
Code names
BPX-501

Resolves to

Compound
UNIIE6349B696W
Targets
P55211CASP9

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Rivogenlecleucel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In